Compugroup Medical (ETR:COP) Given a €53.50 Price Target by Warburg Research Analysts

Warburg Research set a €53.50 ($62.21) target price on Compugroup Medical (ETR:COP) in a report published on Monday, February 4th. The brokerage currently has a buy rating on the stock.

A number of other equities research analysts have also commented on the company. Baader Bank set a €49.00 ($56.98) price target on Compugroup Medical and gave the stock a neutral rating in a research report on Wednesday, November 14th. Commerzbank set a €53.00 ($61.63) price target on Compugroup Medical and gave the stock a buy rating in a research report on Monday, October 22nd. Hauck & Aufhaeuser set a €36.00 ($41.86) price target on Compugroup Medical and gave the stock a sell rating in a research report on Wednesday, October 10th. Deutsche Bank set a €62.00 ($72.09) price target on Compugroup Medical and gave the stock a buy rating in a research report on Tuesday, November 13th. Finally, Berenberg Bank set a €49.00 ($56.98) price target on Compugroup Medical and gave the stock a neutral rating in a research report on Tuesday, November 13th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company’s stock. The stock has a consensus rating of Hold and a consensus target price of €53.07 ($61.71).

Shares of COP traded up €0.50 ($0.58) during mid-day trading on Monday, reaching €51.90 ($60.35). The company had a trading volume of 88,285 shares, compared to its average volume of 68,245. Compugroup Medical has a twelve month low of €40.10 ($46.63) and a twelve month high of €60.30 ($70.12).

Compugroup Medical Company Profile

CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.

See Also: Quiet Period

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.